broth (pH 7.2 - 7.4) dilution methods, in comparison with the
clinical used drugs, ceftriaxone
and methods A
clinical and laboratory study of 300 AVNFH patients, residents of European Russia, was carried
Nouwen, A.,
Deschenes, S.S.,
Balkhiyarova, Z.,
Albertorio-Diaz, J.R.,
Prokopenko, I.,
Schmitz, N. (2021) slightly better fit, the one-factor solution is more parsimonious. Depending on research or
clinical needs
is the only method to
clinically treat CE dysfunction; however, this treatment strategy faces
Zagidullin, N.S.,
Motloch, L.J.,
Musin, T.I.,
Bagmanova, Z.A.,
Lakman, I.A.,
Tyurin, A.V.,
Gumerov, R.M.,
Enikeev, D.,
Cai, B.,
Gareeva, D.F.,
Davtyan, P.A.,
Gareev, D.A. (2021) . Admission ECGs were analyzed, screened for J-waves and correlated to
clinical characteristics and 28-day
Yang, L.,
Luo, W.,
Zhang, Q,
Hong, S.,
Wang, Y.,
Samorodov, A.V.,
Chattipakorn, N.,
Pavlov, V.N.,
Liang, G. (2021) no pharmacological therapy in
clinic. Accumulating evidence has demonstrated that natural compounds from herbs have
Gareev, I.,
Gallyametdinov, A.,
Beylerli, O.,
Valitov, E.,
Alyshov, A.,
Pavlov, V.,
Izmailov, A.,
Zhao, S. (2021) protective equipment, the suspension of
clinical clerkship and supervision, and a reduction in the number